Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma

Digestive Diseases and Sciences

Volumn 51, Issue 10, 2006, Pages 1783-1790

  Upton, Melissa P ^a,b   Nishioka, Norman S ^c   Ransil, Bernard J ^b   Rosenberg, Stanley J ^b   Puricelli, William P ^c   Zwas, Felice R ^d,e   Shields, Helen M ^b,f  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d GREENWICH HOSPITAL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Barrett's epithelium; Dysplasia; Multilayered epithelium; Photodynamic therapy

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; EPITHELIUM; ESOPHAGOSCOPY; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; SEVERITY OF ILLNESS INDEX;

EID: 33846902418     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9243-9     Document Type: Article

References (58)

1. Spechler SJ, Goyal RK (1996) The columnar lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 110:614-621 (Pubitemid 26043897)
2. Falk GW (2002) Barrett's esophagus. Gastroenterology 122:1569-1591
3. Vaezi MF, Singh S, Richter JE (1995) Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies. Gastroenterology 108:1897-1907
4. Menges M, Muller M, Zeitz M (2001) Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 96:331-337
5. Triadafilopoulos G (2001) Acid and bile reflux in Barrett's esophagus: A tale of two evils. Gastroenterology 121:1502-1506
6. Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker III, JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS, Cattau EL Jr (1987) Barrett's esophagus. A prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 92:118-124 (Pubitemid 17207669)
7. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510-513 (Pubitemid 23033424)
8. Cameron AJ, Lomboy CT, Pera M, Carpenter HA (1995) Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 109:1541-1546
9. O'Connor JB, Falk GW, Richter JE (1999) The incidence of adenocarcinoma and dysplasia in Barrett's Esophagus: Report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94:2037-2042 (Pubitemid 29374529)
10. Drewitz DJ, Sampliner RE, Garewal HS (1997) The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92:212-221
11. Provenzale D, Schmitt C, Wong JB (1999) Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 94:2043-2053 (Pubitemid 29374530)
12. Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831 (Pubitemid 29142625)
13. Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review. JAMA 287:1972-1981 (Pubitemid 34326418)
14. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS (2000) Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119:333-338 (Pubitemid 30621983)
15. Peters FTM, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CBHW, Kleibeuker JH (1999) Endoscopic regression of Barrett's oesophagus during omeprazole treatment: A randomized double blind study. Gut 45:489-494 (Pubitemid 29447813)
16. Ye W, Chow WH, Lagergren J, Yin L, Nyren O (2001) Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux disease and after antireflux surgery. Gastroenterology 121:1286-1293 (Pubitemid 33140445)
17. Carlson N, Lechago J, Richter J, Sampliner RE, Peterson L, Santella RM, Goldblum JR, Falk GW, Ertan A, Younes M (2002) Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation. Am J Gastroenterol 97:1340-1345
18. Katzka DA (2002) Barrett's esophagus: Surveillance and treatment. Gastroenterol Clin North Am 31:481-497
19. McDonald ML, Trastek VF, Allen MS (1996) Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg 111:1135-1140 (Pubitemid 26176070)
20. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long term outcome of medical and surgical therapies for gastroesophageal reflux disease: Followup of a randomized controlled trial. JAMA 285:2331-2338 (Pubitemid 32424101)
21. Parrilla P, Martinez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg 237:291-298 (Pubitemid 38176442)
22. Cohen S, Parkman HP (1999) Heartburn: A serious symptom. N Engl J Med 340:878-879
23. Fitzgerald RC, Lascar R, Triadafilopoulos G (2001) Barrett's oesophagus, dysplasia and pharmacologic acid suppression. Aliment Pharmacol Ther 15:269-276 (Pubitemid 32187550)
24. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999) Molecular evolution of the metaplasia-dysplasia- adenocarcinoma sequence in the esophagus. Am J Pathol 154:965-973 (Pubitemid 29169728)
25. Bremner CG, Lynch VP, Ellis FJ Jr (1970) Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 68:209-216
26. Gillen P, Keeling P, Byrne PJ, West AB, Hennessy TPJ (1988) Experimental columnar metaplasia in the canine oesophagus. Br J Surg 75:113-115 (Pubitemid 18078523)
27. Li H, Walsh TN, O'Dowd G, Gillen P, Byrne PJ, Hennessy TPJ (1994) Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. Surgery 115:176-181 (Pubitemid 24057486)
28. Sbarbati A, Faccioli N, Ricci F, Merigo F, Benati D, Castaldini G, Cordiano C, Osculati F (2002) Ultrastructural phenotype of "intestinal- type" cells in columnar-lined esophagus. Ultrastruct Pathol 26:107-111 (Pubitemid 34518162)
29. Shields, HM, Zwas F, Antonioli DA, Doos WG, Kim S, Spechler SJ (1993) Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium. Dig Dis Sci 38:97-108 (Pubitemid 23039459)
30. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS (1997) Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology 112:760-765 (Pubitemid 27113801)
31. Glickman JN, Chen Y, Wang HH, Antonioli DA, Odze RD (2001) Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 25:569-578 (Pubitemid 32423353)
32. Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD (2001) Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 32:1157-1165 (Pubitemid 33104425)
33. Shields HM, Rosenberg SJ, Zwas FR, Ransil BJ, Lembo AJ, Odze R (2001) Prospective evaluation ofmultilayered epithelium in Barrett's esophagus. Am J Gastroenterol 96:3268-3273 (Pubitemid 34016647)
34. Menke-Pluymers MBE, Hop WCJ, Dees J, Van Blankenstein M, Tilanus HW (1993) Risk factors for the development of an adenocarcinoma in the columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group Cancer 72:1155-1158 (Pubitemid 23224979)
35. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ (2000) Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 132:612-620 (Pubitemid 30217553)
36. Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M (1992) Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 33:1155-1158
37. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH (1999) Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 116:277-285 (Pubitemid 29055349)
38. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH (1983) Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14:931-968
39. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, MacDonald W, Owen D (1988) Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19:166-178 (Pubitemid 18091022)
40. Spechler SJ (1999) The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 117:218-228
41. Hayashi GM, Haggitt RC (2001) The histology of Barrett's esophagus: Metaplasia and dysplasia. In: P Sharma, RE Sampliner (eds) Barrett's esophagus and esophageal adenocarcinoma. Blackwell Science, London, pp. 80-88
42. Kerneis S, Pringault E (1999) Plasticity of the gastrointestinal epithelium: The M cell paradigm and opportunism of pathogenic microorganisms. Semin Immunol 11:205-215 (Pubitemid 29358579)
43. Takubo K, Arai T, Sawabe M, Miyashita M, Sasajima K, Iwakiri K, Mafune K (2003) Structures of the normal esophagus and Barrett's esophagus. Esophagus 1:37-47
44. Takubo K (1981) Squamous metaplasia with reserve cell hyperplasia in the esophagogastric junction zone. Acta Pathol Jpn 31:349-359
45. Takubo K, Tsuchiya S, Fukushi K, Shirota A, Mitomo Y (1981) Dysplasia and reserve cell hyperplasia - like change in the human esophagus. Arch Pathol Jpn 31:999-1013 (Pubitemid 12164488)
46. Su Y, Chen X, Klein M, Fang M, Wang S, Yang CS, Goyal RK (2004) Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest 84:753-765 (Pubitemid 38715475)
47. Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C, Sampliner RE (2001) Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 48:310-313 (Pubitemid 32269556)
48. Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL, Reid BJ (2001) P16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 61:8284-8289 (Pubitemid 33091623)
49. Sampliner RE (2002) The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 97:1888-1895
50. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905 (Pubitemid 28304157)
51. Wolfsen HC, Woodward TA, Raimondo M (2002) Photodynamic therapy for dysplastic Barrett's esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77:1176-1181 (Pubitemid 35266366)
52. Hur C, Nishioka NS, Gazelle GS (2003) Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 48:1273-1283 (Pubitemid 36793904)
53. Overholt BF, Panjehpour M, Halberg DL (2003) Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: Long term results. Gastrointest Endosc 58:183-188 (Pubitemid 38220265)
54. Barr H (2001) The role of ablation in the management of high-grade dysplasia. In: HW Tilanus, SEA Attwood (eds) Barrett's esophagus. Kluwer Academic Publishers, The Netherlands, pp. 259-272
55. Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA (1998) The histopathology of treated Barrett's esophagus: Squamous reepithelization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 22:239-245 (Pubitemid 28113386)
56. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS (1993) Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 104:1686- 1691
57. Wieczorek TJ, Wang HH, Antonioli DA, Glickman JN, Odze RD (2003) Pathologic features of reflux and Helicobacter pylori-associated carditis: A comparative study. Am J Surg Pathol 27:960-968 (Pubitemid 36758899)
58. Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD (2002) Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol 26:1032-1039 (Pubitemid 34810564)